Αποτελέσματα Αναζήτησης
1 Μαΐ 2018 · Most clinical trials cover the cost of the experimental medication and some help to cover travel costs as well as scans when needed. If you cannot afford a standard treatment, a clinical trial may be a way to receive treatment while minimizing out-of-pocket costs.
This trial, Minus Anthracycline or Short-Term versus Epirubicin and Cyclophosphamide followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy (MASTER), was designed to prospectively test the hypothesis that six cycles of TC are non-inferior to standard AT-containing chemotherapy (EC-P, four cycles of epirubicin and cyclophosphamide ...
This treatment regimen consists of two parts: 4 cycles of AC, followed by 4 cycles of TH and 13 cycles of trastuzumab. Breast neoadjuvant/adjuvant AC (DOXOrubicin and CYCLOPHOSPHamide) three weekly. Breast adjuvant TH (DOCEtaxel and trastuzumab) three weekly.
14 Αυγ 2024 · Neoadjuvant pembrolizumab plus chemotherapy (P + CT) has emerged as a standard of care for stage II-III triple-negative breast cancer (TNBC). However, the best anthracycline-cyclophosphamide...
19 Ιουν 2024 · With a primary endpoint of 5-year iDFS, the investigators were able to demonstrate considerable improvements to iDFS for those on a trastuzumab-containing regimen (AC-TH or TCH).
18 Αυγ 2021 · The noninferiority of an anthracycline-free regimen was first suggested in the adjuvant BCIRG-006 trial, which randomly assigned 3,222 patients with operable HER2-positive BC to receive either doxorubicin-cyclophosphamide followed by docetaxel (AC-T), AC-T plus trastuzumab (AC-TH), or docetaxel, carboplatin, and trastuzumab (TCbH).
2 Σεπ 2021 · To analyze the cost-effectiveness of Doxorubicin/cyclophosphamide/Paclitaxel/trastuzumab (AC-TH) and Docetaxel/Carboplatin/trastuzumab (TCH). Methods. A Markov model was built to simulate the process of breast cancer events and death occurred in both AC-TH and TCH armed patients and to choose a suitable chemotherapy method.
